Antimicrobial resistance Trends

 

Antimicrobial resistance Trends

Patients with infections caused by drug-resistant bacteria are at increased risk of worse clinical outcomes and death, and consume more health care resources than patients infected with nonresistant strains of the same bacteria.

 

We are finding that we can't fight infections the same way that we did in the past and need to have advances with new products or revised products to combat this area.

These companies are working in this area:

Paratek Corp. (NASDAQ:PRTK)

Nabriva Therapeutics (NASDAQ:NBRV),

Cempra (NASDAQ:MLNT)

Comments

Popular posts from this blog

Fossil Fuel not dead yet

All is flashing in 2023 for a good year

3D Printing